Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
PTC Therapeutics, Inc. (PTCT)  
$33.62 0.54 (1.58%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,552,000
Market Cap: 3.04(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.07 - $59.1
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8
Insider 3/6 Months : 8.6
Guru Rank Number :  538
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 7,700 7,700 7,700
Total Buy Value $0 $198,736 $198,736 $198,736
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 5,981 52,172 114,858 280,340
Total Sell Value $151,224 $1,447,501 $4,819,149 $12,887,777
Total People Sold 3 8 10 15
Total Sell Transactions 4 26 35 88
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 524
  Page 10 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pauwels Eric Chief Business Officer   •       –      –    2021-01-25 4 S $62.05 $26,745 D/D (431) 36,849 38%     
   Peltz Stuart Walter Chief Executive Officer   •       •      –    2021-01-25 4 S $62.05 $21,719 I/I (350) 15,364 38%     
   Hill Emily Luisa Chief Financial Officer   •       –      –    2021-01-25 4 S $62.05 $17,065 D/D (275) 23,847 38%     
   Klein Matthew B. Chief Development Officer   •       –      –    2021-01-15 4 AS $69.09 $297,078 D/D (4,300) 19,309 -43%     
   Klein Matthew B. Chief Development Officer   •       –      –    2021-01-15 4 OE $38.98 $167,614 D/D 4,300 23,609     -
   Utter Christine Marie SVP, Finance & CAO   •       –      –    2021-01-13 4 AS $66.57 $262,752 D/D (3,947) 17,529 -41%     
   Utter Christine Marie SVP, Finance & CAO   •       –      –    2021-01-13 4 OE $11.23 $53,874 D/D 3,288 20,029     -
   Klein Matthew B. Chief Development Officer   •       –      –    2021-01-08 4 AS $69.48 $383,410 D/D (5,500) 19,309 -44%     
   Klein Matthew B. Chief Development Officer   •       –      –    2021-01-08 4 OE $38.98 $214,390 D/D 5,500 24,809     -
   Hill Emily Luisa Chief Financial Officer   •       –      –    2021-01-08 4 AS $69.75 $1,815,802 D/D (26,033) 24,122 -44%     
   Hill Emily Luisa Chief Financial Officer   •       –      –    2021-01-08 4 OE $11.23 $613,409 D/D 26,033 33,400     -
   Almstead Neil Gregory Chief Technical Ops Officer   •       –      –    2021-01-08 4 AS $69.00 $89,700 I/I (1,300) 2,388 -44%     
   Almstead Neil Gregory Chief Technical Ops Officer   •       –      –    2021-01-08 4 OE $27.05 $35,165 I/I 1,300 3,688     -
   Klein Matthew B. Chief Development Officer   •       –      –    2021-01-07 4 AS $68.98 $268,056 D/D (3,886) 19,309 -45%     
   Klein Matthew B. Chief Development Officer   •       –      –    2021-01-07 4 OE $38.98 $151,476 D/D 3,886 23,195     -
   Peltz Stuart Walter Chief Executive Officer   •       •      –    2021-01-06 4 A $0.00 $0 I/I 3,960 15,714     -
   Peltz Stuart Walter Chief Executive Officer   •       •      –    2021-01-06 4 A $0.00 $0 D/D 27,600 82,283     -
   Utter Christine Marie SVP, Finance & CAO   •       –      –    2021-01-06 4 A $0.00 $0 D/D 8,700 18,188     -
   Boulding Mark Elliott Exec. VP and CLO   •       –      –    2021-01-06 4 A $0.00 $0 D/D 10,200 49,152     -
   Steele Glenn Jr Md Director   –       •      –    2021-01-06 4 A $0.00 $0 D/D 1,650 3,300     -
   Zeldis Jerome B Director   –       •      –    2021-01-06 4 A $0.00 $0 D/D 1,650 3,300     -
   Almstead Neil Gregory Chief Technical Ops Officer   •       –      –    2021-01-06 4 A $0.00 $0 I/I 600 2,388     -
   Almstead Neil Gregory Chief Technical Ops Officer   •       –      –    2021-01-06 4 A $0.00 $0 D/D 10,200 36,787     -
   Hill Emily Luisa Chief Financial Officer   •       –      –    2021-01-06 4 A $0.00 $0 D/D 10,800 24,122     -
   Schmertzler Michael Director   –       •      –    2021-01-06 4 A $0.00 $0 D/D 3,300 103,366     -
  524 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us